Glucagon like Peptide 1 News and Research

RSS

Ketogenic diets, gut microbiota, and health effects

The evidence on ketogenic diets (KDs) from the past three decades.

24 Aug 2023

$9.57 million grant will support a clinical trial to study new treatment option for NAFLD

According to the National Institutes of Health, approximately 24% of adults in the United States have nonalcoholic fatty liver disease (NAFLD), an umbrella term for a range of liver conditions affecting people who drink little to no alcohol that can lead to cirrhosis, liver cancer and liver failure.

23 Aug 2023

Study finds altered brain connectivity in people with obesity

For the first time, researchers have discovered that the ventral tegmental area (VTA) of the brain - a key structure involved in motivation and reward appreciation has altered connectivity patterns with specific brain regions in patients with obesity.

22 Aug 2023

Study explores mechanism behind liraglutide-associated weight loss in obese individuals

A new study suggests that liraglutide is associated with the normalization of associative learning in obese individuals with insulin resistance.

22 Aug 2023

Obesity impairs brain's ability to learn associations

To control our behavior, the brain must be able to form associations. This involves, for example, associating a neutral external stimulus with a consequence following the stimulus (e.g., the hotplate glows red - you can burn your hand).

17 Aug 2023

Study: 93 million U.S. adults may benefit from semaglutide medication

Researchers from the University of California, Irvine have just published a study that projects 93 million U.S. adults that are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy.

16 Aug 2023

Can fasting benefit individuals with diabetes?

Fasting and its effect on diabetes.

15 Aug 2023

Revolutionizing type 2 diabetes treatment: personalized approach shows promise in matching patients with optimal glucose-lowering therapies

A personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes.

10 Aug 2023

Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service

Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, today announced it has received notification from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) that the Company is now a member of the UK GLP (Good Laboratory Practice) Compliance Monitoring Programme, and is, therefore, able to offer GLP compliant hERG ion channel screening services to the global life sciences community.

From Metrion Biosciences Limited 7 Aug 2023

Unlocking the potential of Reg3γ: new insights into its metabolic functions and therapeutic prospects

Researchers evaluated the physiological roles of an antimicrobial peptide.

3 Aug 2023

The microbiota connection, gut health linked to metabolic syndrome prevalence

The relationship between gut microbiota and metabolic disorders focused on BA metabolism and immunity.

1 Aug 2023

Bruker launches portable MOBILE-IR II spectrometer to bring laboratory-grade FT-IR analysis to the field

Bruker Optics announces the launch of the MOBILE-IR II – a portable, battery-powered Fourier Transform Infrared (FT-IR) spectrometer that delivers the high spectral performance of a laboratory benchtop system. This powerful mobile spectrometer will enable users worldwide to bring routine and advanced FT-IR applications to the field.

From Bruker Optics 12 Jul 2023

Produce prescription programs could save US healthcare system $40 billion

An apple a day not only keeps the doctor away, it also could save the United States at least $40 billion in medical bills, report Friedman School of Nutrition Science and Policy at Tufts University researchers in a new study published July 7 in the Journal of the American Heart Association.

7 Jul 2023

Timing, type, and frequency of exercise are crucial components for optimal glycemic control in type 2 diabetes

Exercise plays a crucial role in managing type 2 diabetes, offering potential benefits such as improved glycemic control. This study explores exercise recommendations and their impact on dietary, medication, and behavioral factors for optimal diabetes care.

5 Jul 2023

Glucagon like Peptide 1 News and Research

Ketogenic diets, gut microbiota, and health effects

$9.57 million grant will support a clinical trial to study new treatment option for NAFLD

Study finds altered brain connectivity in people with obesity

Study explores mechanism behind liraglutide-associated weight loss in obese individuals

Obesity impairs brain's ability to learn associations

Study: 93 million U.S. adults may benefit from semaglutide medication

Can fasting benefit individuals with diabetes?

Revolutionizing type 2 diabetes treatment: personalized approach shows promise in matching patients with optimal glucose-lowering therapies

Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service

Unlocking the potential of Reg3γ: new insights into its metabolic functions and therapeutic prospects

The microbiota connection, gut health linked to metabolic syndrome prevalence

Bruker launches portable MOBILE-IR II spectrometer to bring laboratory-grade FT-IR analysis to the field

Produce prescription programs could save US healthcare system $40 billion

Timing, type, and frequency of exercise are crucial components for optimal glycemic control in type 2 diabetes

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Higher doses of oral semaglutide effective in lowering blood sugar and promoting weight loss

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News